NCT04249622 2025-09-16Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast CancerMayo ClinicPhase 2 Terminated20 enrolled 13 charts
NCT04379570 2025-09-08Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal TherapyAlliance for Clinical Trials in OncologyPhase 3 Active not recruiting1,167 enrolled
NCT05243056 2025-08-01A Quality of Life Intervention for Young African American Breast Cancer Survivors in TreatmentUniversity of Alabama at BirminghamPhase NA Recruiting40 enrolled
NCT05568472 2025-04-03Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN StudySWOG Cancer Research NetworkPhase NA Active not recruiting565 enrolled